Baseimmune

Develops computationally designed antigens for active immunotherapies targeting chronic diseases

London, United KingdomFounded 2019baseimmune.co.ukWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

About Baseimmune

Baseimmune combines computational design and protein engineering to create bespoke antigens for active immunotherapies targeting chronic diseases.

The company is based in London and was founded in 2019.

Product: A platform that designs bespoke antigens for active immunotherapies targeting chronic diseases.

Jobs at Baseimmune

No open positions listed right now.

More biotech & pharma companies

  • BDD Pharma

    Integrated early-stage drug development, GMP manufacturing and Phase I clinical trial services for pharmaceutical and biotech companies
    Glasgow, United KingdomBiotech & pharmaFounded 2000
    New on Evolc
  • Besins Healthcare (UK)

    Pharmaceutical company developing and commercialising reproductive hormone treatments for patients and healthcare professionals in the UK
    Holborn, United KingdomBiotech & pharmaFounded 2013
  • Beta Pharmaceuticals

    Pharmaceutical wholesaler supplying generic, branded and OTC medicines and healthcare products to UK and international customers
    Witham, United KingdomBiotech & pharmaFounded 2003
  • Bicycle Therapeutics

    Develops precision-guided therapeutics for cancer and other diseases using Bicycle molecules
    Cambridge, United KingdomBiotech & pharmaFounded 20173 open jobs
    Remote-friendly
  • Bigespas

    Develops a Latrepirdine-derived drug candidate for Alzheimer’s disease
    London, United KingdomBiotech & pharmaFounded 2020
    New on Evolc
  • Biocaptiva

    Develops cfDNA capture polymers and extraction kits for laboratories conducting liquid-biopsy research and testing
    Edinburgh, United KingdomBiotech & pharmaFounded 2018

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Hosting

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.